Drug Maker Drops Patent Appeal
Mayne Pharma said Tuesday Sanofi would not proceed with its appeal against a U.K. High Court ruling in favor of Mayne’s bid to launch a version of the drug.
The case involved patents for Sanofi’s oxaliplatin product, which is sold under the brand name Eloxatin.
Worldwide sales for the drug, which is used in the treatment of colon cancer, jumped 23% in financial year 2005 to...
To view the full article, register now.